Renal Cancer - Results from #2600

Current evidence on screening for renal cancer. September 1, 2020

Efficacy and safety of apatinib monotherapy in metastatic renal cell carcinoma (mRCC) patients: A single-arm observational study. August 31, 2020

Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). August 31, 2020

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma. August 28, 2020

LINC00973 involves in cancer immune suppression through positive regulation of Siglec-15 in ccRCC. August 28, 2020

Registrations of Patients with Renal Cell Carcinoma in the Nationwide Danish Renal Cancer Database versus the Danish Cancer Registry: Data Quality, Completeness and Survival (DaRenCa Study-3). August 28, 2020

Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma. August 27, 2020

Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma. August 27, 2020

Renal Cell Carcinoma: Predicting DNA Methylation Subtyping and Its Consequences on Overall Survival With Computed Tomography Imaging Characteristics. August 27, 2020

Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis. August 26, 2020

Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: evidence for further locus heterogeneity. August 26, 2020

A preoperative model to predict pT3 upstaging in clinically localized renal cell carcinoma. August 26, 2020

ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3. August 25, 2020

Exosome-mediated miR-9-5p promotes proliferation and migration of renal cancer cells both in vitro and in vivo by targeting SOCS4. August 25, 2020

DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma. August 25, 2020

Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib. August 25, 2020

Exelixis Announces Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for CABOMETYX® (cabozantinib) in Combination With Opdivo® (nivolumab) for Advanced Renal Cell Carcinoma August 24, 2020

Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma. August 24, 2020

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma. August 24, 2020

LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. August 24, 2020

Page 131 of 459